Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tozuleristide and Canvas System in Pediatric CNS Tumors
NCT03579602Phase 3Completed
- Sponsor
- Blaze Bioscience
- Start
- Nov 2018
- Primary completion
- Apr 2022
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of tozuleristide in central nervous system tumor, sponsored by Blaze Bioscience. Started Nov 2018; status: completed.
02
Drugs
tozuleristide
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on NCT03579602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579602.